Latest stories on IMTX
Immatics and 4 More Stocks See Activist Action
Barron's55 · neutralgeneral
Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma
Seeking Alpha56 · neutralanalyst
Immatics price target lowered to $17 from $18 at Jefferies
The Fly38 · neutralanalyst
Immatics’ $150 Million Underwritten Offering Set to Fuel PRAME-Targeted Cancer Therapies
August 25, 2026
MarketChameleon28 · bearishgeneral
Why is Immatics stock climbing today?
Investing.com Markets50 · neutralgeneral
Immatics announces $150M offering of common stock priced at $8.69 per share
The Fly26 · bearishgeneral
Immatics launches $150M securities offering
Seeking Alpha24 · bearishgeneral
Immatics Announces $150 Million Underwritten Offering
GlobeNewswire24 · bearishgeneral
Immatics Announces $150 Million Underwritten Offering
Business Insider28 · bearishgeneral
Immatics reports Q2 EPS (46c), consensus (48c)
The Fly42 · neutralearnings
Immatics GAAP EPS of -€0.46, revenue of €9.14M
Seeking Alpha34 · bearishearnings
Immatics Announces Second Quarter 2026 Financial Results and Business Update
GlobeNewswire50 · neutralearnings
Immatics Announces Second Quarter 2026 Financial Results and Business Update
Business Insider50 · neutralgeneral
Immatics Announces Second Quarter 2026 Financial Results and Business Update
StockTitan50 · neutralgeneral
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026 | IMTX Stock News
StockTitan56 · neutralproduct/pr
Immatics: PRAME Is Becoming More Than A Single-Asset Story
Seeking Alpha67 · bullishproduct/pr